TMCI Treace Medical Concepts, Inc.

NASDAQ
$4.50

Treace Medical Concepts, Inc. (TMCI) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $0.25 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -12.3% since its last earnings release on August 7, 2026.

Treace Medical Concepts Beat Consensus Estimates, Narrows Guidance
Friday, August 7, 2026 · 7:05 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 7:05 AM ET
Earnings Whisper
-
vs ($0.25)
Rev est $47.69M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.62

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Treace Medical Concepts, Inc.

Treace Medical Concepts is a commercial-stage orthopaedic medical device company with the goal of advancing the standard of care for the surgical management of bunion deformities.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.